- Home
- AVDX vs TWST Comparison
AVDX vs TWST Comparison
Compare AVDX & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDX
- TWST
- Stock Information
- Founded
- AVDX 2000
- TWST 2013
- Country
- AVDX United States
- TWST United States
- Employees
- AVDX N/A
- TWST N/A
- Industry
- AVDX EDP Services
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVDX Technology
- TWST Health Care
- Exchange
- AVDX Nasdaq
- TWST Nasdaq
- Market Cap
- AVDX 2.1B
- TWST 2.3B
- IPO Year
- AVDX 2021
- TWST 2018
- Fundamental
- Price
- AVDX $10.01
- TWST $31.17
- Analyst Decision
- AVDX Hold
- TWST Buy
- Analyst Count
- AVDX 14
- TWST 9
- Target Price
- AVDX $9.73
- TWST $48.56
- AVG Volume (30 Days)
- AVDX 2.0M
- TWST 1.9M
- Earning Date
- AVDX 11-05-2025
- TWST 11-17-2025
- Dividend Yield
- AVDX N/A
- TWST N/A
- EPS Growth
- AVDX N/A
- TWST N/A
- EPS
- AVDX N/A
- TWST N/A
- Revenue
- AVDX $446,722,000.00
- TWST $362,273,000.00
- Revenue This Year
- AVDX $5.52
- TWST $22.11
- Revenue Next Year
- AVDX $9.64
- TWST $17.50
- P/E Ratio
- AVDX N/A
- TWST N/A
- Revenue Growth
- AVDX 8.04
- TWST 22.72
- 52 Week Low
- AVDX $6.61
- TWST $24.07
- 52 Week High
- AVDX $11.68
- TWST $55.33
- Technical
- Relative Strength Index (RSI)
- AVDX 70.73
- TWST 58.48
- Support Level
- AVDX $9.89
- TWST $30.65
- Resistance Level
- AVDX $10.02
- TWST $33.86
- Average True Range (ATR)
- AVDX 0.02
- TWST 2.03
- MACD
- AVDX 0.00
- TWST 0.27
- Stochastic Oscillator
- AVDX 87.37
- TWST 63.80
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.